Matches in Wikidata for { <http://www.wikidata.org/entity/Q56785856> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q56785856 description "article" @default.
- Q56785856 description "im Februar 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56785856 description "wetenschappelijk artikel" @default.
- Q56785856 description "наукова стаття, опублікована в лютому 2008" @default.
- Q56785856 description "հոդված" @default.
- Q56785856 description "ലേഖനം" @default.
- Q56785856 name "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 name "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 type Item @default.
- Q56785856 label "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 label "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 prefLabel "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 prefLabel "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 P1433 Q56785856-F46968A0-BCE1-4BCD-AB77-AEDF1A8CC259 @default.
- Q56785856 P1476 Q56785856-4D9F9F09-9B94-4777-95BC-53C50D8854EA @default.
- Q56785856 P2093 Q56785856-0B57213F-68A9-47EF-9AB5-F9141F9DA70D @default.
- Q56785856 P2093 Q56785856-13211AAB-48B8-475A-83EA-6A711D68BCE2 @default.
- Q56785856 P2093 Q56785856-3325E3A1-FAC1-485D-9731-031BC78061E8 @default.
- Q56785856 P2093 Q56785856-45C8A3A6-76C0-424B-8AFE-04E454A8CCA6 @default.
- Q56785856 P2093 Q56785856-4A73FC76-CEB6-41AC-9F07-DDE60CD35FA3 @default.
- Q56785856 P2093 Q56785856-7DF82701-CFF3-4BA2-8598-796C5CFEFB14 @default.
- Q56785856 P2093 Q56785856-8A5EFE2D-56FB-42BD-8D82-80236D46E86D @default.
- Q56785856 P2093 Q56785856-AE6722B5-D4ED-4AE2-9BBC-DD7BC7A8709E @default.
- Q56785856 P2093 Q56785856-B28AA5F9-6A95-49B8-B8C9-0E75F2E4AAF8 @default.
- Q56785856 P2093 Q56785856-C3226A81-4E7F-413F-9B9C-0EA61DE7B38D @default.
- Q56785856 P2093 Q56785856-EEE749D6-AE6E-43A1-942F-F31DF896C6EF @default.
- Q56785856 P2093 Q56785856-F44CA715-4AF4-47BA-9B11-CCF7941B68B1 @default.
- Q56785856 P2093 Q56785856-F5420E60-0F26-4E63-948A-72E5E514971F @default.
- Q56785856 P304 Q56785856-48AD5262-AC20-4C61-B7B3-9E4BA0EFC1C7 @default.
- Q56785856 P31 Q56785856-DE7685F9-3481-47C1-B05A-0A85F153A606 @default.
- Q56785856 P356 Q56785856-F237809C-0D91-44AA-B3A0-94FBB9E1E4AC @default.
- Q56785856 P433 Q56785856-40CC06C4-C0B5-4746-84B3-48112743FC22 @default.
- Q56785856 P478 Q56785856-99BB51D1-DA50-4F01-9B51-531ED46A5798 @default.
- Q56785856 P50 Q56785856-5D0C8183-BEF5-44C3-A2C2-687C425C2981 @default.
- Q56785856 P50 Q56785856-8649697F-F12D-4D07-BA95-54726BCA2D06 @default.
- Q56785856 P50 Q56785856-EC345AFE-6562-4E80-BE32-D673F3C8C513 @default.
- Q56785856 P577 Q56785856-6D260FC4-3497-4977-A839-AAB3E14765AF @default.
- Q56785856 P698 Q56785856-2D8E02C3-86B1-4700-85AD-09BC9813D4E1 @default.
- Q56785856 P921 Q56785856-07f1efa9-ce86-42e9-8ad0-b8a9e35a1751 @default.
- Q56785856 P921 Q56785856-23A88A64-3767-4A2A-AB73-E90FD604B9B4 @default.
- Q56785856 P921 Q56785856-6F580F0E-B775-4968-851E-97D03BD1C575 @default.
- Q56785856 P921 Q56785856-B0B4E8B3-2939-4A15-9E7A-C1FF57DD7958 @default.
- Q56785856 P921 Q56785856-E342AF7C-D650-4D12-BF93-3D401011A23F @default.
- Q56785856 P356 JIR.2007.0064 @default.
- Q56785856 P698 18279104 @default.
- Q56785856 P1433 Q15754749 @default.
- Q56785856 P1476 "Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy" @default.
- Q56785856 P2093 "Alice Benson" @default.
- Q56785856 P2093 "Beverly E. Sha" @default.
- Q56785856 P2093 "Brian G. Gazzard" @default.
- Q56785856 P2093 "Delanie J. Cassell" @default.
- Q56785856 P2093 "Jacob P. Lalezari" @default.
- Q56785856 P2093 "Peter E. Pertel" @default.
- Q56785856 P2093 "Prabhu Rajagopalan" @default.
- Q56785856 P2093 "Richard B. Pollard" @default.
- Q56785856 P2093 "Richard T. Davey" @default.
- Q56785856 P2093 "Robert A. Salata" @default.
- Q56785856 P2093 "Ronald T. Mitsuyasu" @default.
- Q56785856 P2093 "Shurjeel Choudhri" @default.
- Q56785856 P2093 "Yves Levy" @default.
- Q56785856 P304 "89-100" @default.
- Q56785856 P31 Q13442814 @default.
- Q56785856 P356 "10.1089/JIR.2007.0064" @default.
- Q56785856 P433 "2" @default.
- Q56785856 P478 "28" @default.
- Q56785856 P50 Q106615453 @default.
- Q56785856 P50 Q37367057 @default.
- Q56785856 P50 Q6834090 @default.
- Q56785856 P577 "2008-02-01T00:00:00Z" @default.
- Q56785856 P698 "18279104" @default.
- Q56785856 P921 Q101929 @default.
- Q56785856 P921 Q194908 @default.
- Q56785856 P921 Q323936 @default.
- Q56785856 P921 Q7141 @default.
- Q56785856 P921 Q7215 @default.